首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors
【24h】

Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors

机译:羧基苄基取代的8-(3-(R)-氨基哌啶-1-基)-7-(2-氯/氰基苄基)-3-甲基-3,7-二氢嘌呤-2,6的合成及强抑制活性-二酮作为二肽基肽酶IV(DPP-IV)抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Fourteen 3-methyl-3,7-dihydro-purine-2,6-dione derivatives 1-14 bearing carboxybenzyl and 2-chloro/cyanobenzyl groups at the N-1 and N-7 positions, respectively, were synthesized as dipeptidyl peptidase IV (DPP-IV) inhibitors. These compounds were characterized on the basis of NMR (H-1 and C-13) and ESI MS data. In vitro bioassay indicates that most of these compounds showed moderate to good inhibitory activities against DPP-IV. Among them, compound 13 (IC50 = 36 nM) exhibited comparable activity with a positive control, Sitagliptin (IC50 = 16 nM). In addition, the structure-activity relationship of these compounds is also briefly discussed. (C) 2015 Elsevier Ltd. All rights reserved.
机译:合成十四个分别在N-1和N-7位带有羧基苄基和2-氯/氰基苄基的3-甲基-3,7-二氢嘌呤-2,6-二酮衍生物1-14,作为二肽基肽酶IV (DPP-IV)抑制剂。这些化合物是根据NMR(H-1和C-13)和ESI MS数据进行表征的。体外生物测定表明,这些化合物大多数对DPP-IV表现出中等至良好的抑制活性。其中,化合物13(IC50 = 36 nM)表现出与阳性对照西格列汀(Sitagliptin)(IC50 = 16 nM)相当的活性。另外,还简要讨论了这些化合物的结构-活性关系。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号